79 related articles for article (PubMed ID: 3577958)
1. [Experimental study of chemotherapy of renal cell carcinoma. 1. Combination effect through the use of cell kinetics-directed treatment schedules].
Konami T
Hinyokika Kiyo; 1987 Jan; 33(1):1-14. PubMed ID: 3577958
[TBL] [Abstract][Full Text] [Related]
2. [Experimental study of chemotherapy of renal cell carcinoma. 2. Combination effect of interferon and antitumor agents based on cell kinetic analysis].
Konami T
Hinyokika Kiyo; 1987 Jan; 33(1):15-26. PubMed ID: 3577963
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy of renal cell carcinoma: experimental study and clinical effect].
Kanda H; Matsuura T; Akiyama T; Kurita T
Hinyokika Kiyo; 1988 Nov; 34(11):1879-84. PubMed ID: 3242362
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of selected drug combinations on the growth of a human pancreatic carcinoma cell line (MIA PaCa-2).
Fountzilas G; Gratzner H; Lim LO; Yunis AA
J Natl Cancer Inst; 1986 Jan; 76(1):37-43. PubMed ID: 3455740
[TBL] [Abstract][Full Text] [Related]
5. [Cell cycles of cancer cells and chemotherapy--flow cytometric observation of the effects of chemotherapeutic agents on cell kinetics of cultured human lung cancer cells].
Shimizu T
Hokkaido Igaku Zasshi; 1983 Sep; 58(5):467-82. PubMed ID: 6662482
[TBL] [Abstract][Full Text] [Related]
6. Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture.
Kano Y; Ohnuma T; Okano T; Holland JF
Cancer Res; 1988 Jan; 48(2):351-6. PubMed ID: 3422052
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with adriamycin and interleukin 2 augments immunity against murine renal cell carcinoma.
Gautam SC; Chikkala NF; Ganapathi R; Hamilton TA
Cancer Res; 1991 Nov; 51(22):6133-7. PubMed ID: 1682042
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis may be either suppressed or enhanced with strategic combinations of antineoplastic drugs or anti-IgM.
Lin CK; Nguyen TT; Morgan TL; Mei RL; Kaptein JS; Kalunta CI; Yen CF; Park E; Zou HY; Lad PM
Exp Cell Res; 1998 Oct; 244(1):1-13. PubMed ID: 9770343
[TBL] [Abstract][Full Text] [Related]
9. [Effect of various anti-cancer drugs on human renal cell carcinoma serially transplanted into nude mice].
Honda N
Hinyokika Kiyo; 1986 Oct; 32(10):1423-41. PubMed ID: 3565179
[TBL] [Abstract][Full Text] [Related]
10. Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma.
Kato Y; Yoshimura K; Shin T; Verheul H; Hammers H; Sanni TB; Salumbides BC; Van Erp K; Schulick R; Pili R
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4538-46. PubMed ID: 17671140
[TBL] [Abstract][Full Text] [Related]
11. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.
Weber KL; Doucet M; Price JE; Baker C; Kim SJ; Fidler IJ
Cancer Res; 2003 Jun; 63(11):2940-7. PubMed ID: 12782601
[TBL] [Abstract][Full Text] [Related]
12. [Flow cytometric analysis of the effect of THP-adriamycin on the cell cycle traverse of RPMI-8402 cells--comparison with adriamycin].
Takamoto S; Ota K
Gan To Kagaku Ryoho; 1986 May; 13(5):1868-75. PubMed ID: 3707149
[TBL] [Abstract][Full Text] [Related]
13. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
Tyagi AK; Singh RP; Agarwal C; Chan DC; Agarwal R
Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642
[TBL] [Abstract][Full Text] [Related]
14. Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs.
Verheul HM; Qian DZ; Carducci MA; Pili R
Cancer Chemother Pharmacol; 2007 Aug; 60(3):329-39. PubMed ID: 17256134
[TBL] [Abstract][Full Text] [Related]
15. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R
Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929
[TBL] [Abstract][Full Text] [Related]
16. Anticancer chemosensitivity profiles of human breast cancer cells assessed by in vitro DNA synthesis inhibition assay.
Nio Y; Tamura K; Kan N; Inamoto T; Ohgaki K; Kodama H
Anticancer Res; 2000; 20(2B):1237-44. PubMed ID: 10810427
[TBL] [Abstract][Full Text] [Related]
17. Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model.
Plum SM; Hanson AD; Volker KM; Vu HA; Sim BK; Fogler WE; Fortier AH
Clin Cancer Res; 2003 Oct; 9(12):4619-26. PubMed ID: 14555538
[TBL] [Abstract][Full Text] [Related]
18. Optimum time sequence for the administration of cyclophosphamide and other drugs in vivo.
Mattern J; Wauss K; Volm M
Anticancer Res; 1985; 5(2):173-8. PubMed ID: 4039550
[TBL] [Abstract][Full Text] [Related]
19. [Combination chemotherapy with aclarubicin and cisplatinum against malignant intracranial tumor--an in vitro study].
Ishiyama J; Yoshida J; Wakabayashi T; Kageyama N
Gan To Kagaku Ryoho; 1987 Feb; 14(2):479-84. PubMed ID: 3468884
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.
Drevs J; Fakler J; Eisele S; Medinger M; Bing G; Esser N; Marmé D; Unger C
Anticancer Res; 2004; 24(3a):1759-63. PubMed ID: 15274352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
